Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors

Clinical trial NCT00859937 · COMPLETED

Trial details

NCT number: NCT00859937
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Salivary Gland Neoplasm Recurrent Salivary Gland Carcinoma Salivary Gland Adenoid Cystic Carcinoma Stage IV Major Salivary Gland Cancer AJCC v7

Start date: 2009-03-16
Primary completion: 2013-01-30
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.